PanAgora Asset Management »

Maxcyte shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $110k 89k 1.23

More positions owned by PanAgora Asset Management

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Inc-cl A Common (GOOGL)
Amazon.com Common (AMZN)
Broadcom Common (AVGO)
Alphabet Inc-cl C Common (GOOG)
Micron Technology Common (MU)
Advanced Micro Devices Common (AMD)
Meta Platforms Inc-class A Common (META)
Eli Lilly & Co Common (LLY)
Tesla Common (TSLA)
Lam Research Corp Common (LRCX)
General Electric Common (GE)
Bank Of America Corp Common (BAC)

View all positions for PanAgora Asset Management

Top funds holding Maxcyte

Capricorn Fund Managers
Vitruvian Partners
Vanguard Capital Management
Morgan Stanley
Mudita Advisors
BlackRock
Brooklands Fund Management
Bnp Paribas Investment Partners
Cadian Capital Management
State Street Corporation
Peapod Lane Capital
Renaissance Technologies
AQR Capital Management
Jane Street
Two Sigma Investments

View all funds holding Maxcyte